SUBSCRIBE
SUBSCRIBE

Inceptor Bio

NEWS
Business
SPONSORED: Closing the Opportunity Gap--How Inceptor Bio Supports Women Leaders
Women are often at the forefront of innovation, making up nearly half of the life sciences industry despite a shrinking but persistent wage gap. Inceptor Bio is at the forefront of closing inequality.
March 8, 2023
 · 
2 min read
 · 
Lisa Munger
Drug Development
Money on the Move: Biotechs Target Cancers, Dermatology and Strokes
Private investors, governmental institutions and longtime life sciences investors provided funding to develop therapies for cancers, dermatological problems and acute ischemic strokes.
May 25, 2022
 · 
4 min read
 · 
Hannah Chudleigh
Inceptor Bio CEO Shailesh Maingi/Courtesy of Incep
Bio NC
Inceptor Bio Snags $37M for Three-Pronged Immuno-Oncology Platforms
Fueled by $37 million in Series A financing, N.C.-based Inceptor Bio is advancing three, next-generation approaches to immuno-oncology, including a CAR-T program that is expected to be in the clinic next year.
May 20, 2022
 · 
4 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Press Releases
Inceptor Bio and GRIT Bio Announce Strategic Partnership to Advance IB-T101, a Next-Generation Solid Tumor CAR-T Utilizing the OUTLAST™ Platform
December 19, 2024
 · 
3 min read
Business
Inceptor Bio Appoints Matthias Schroff, PhD, as Chief Executive Officer
May 8, 2023
 · 
1 min read
Business
Inceptor Bio Announces Strategic Collaboration with University of Minnesota to Develop Novel iPSC Platform for the Advancement of Next-Generation Allogeneic Cell Therapies
June 30, 2022
 · 
2 min read
Bio NC
Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for Difficult-to-Treat Cancers
May 19, 2022
 · 
3 min read
Bio NC
Inceptor Bio Enters into In-licensing Agreement with University of California, Santa Barbara For CAR-M Platform
December 16, 2021
 · 
2 min read
Deals
Inceptor Bio Announces Agreement to Acquire Gainesville, FL GMP Facility And Transfer Operating Team From Arranta Bio To Accelerate Cell Therapies To Cure Cancer
October 27, 2021
 · 
3 min read
Business
Inceptor Bio Announces The Appointment Of Dr. Mark J. Gilbert As Chair Of Its Scientific Advisory Board
July 28, 2021
 · 
3 min read
Bio NC
Inceptor Bio Launches FastBack Bio, Its First Portfolio Company Developing A Novel CAR-T Platform That Targets Difficult-To-Treat Cancers
July 7, 2021
 · 
4 min read
Bio NC
Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers
June 14, 2021
 · 
4 min read